Literature DB >> 28205136

A comparative study of the risk profile of hemodialysis patients in a for profit network and in two regional registries of the Italian Society of Nephrology.

Maurizio Postorino1, Claudia Amato2, Elena Mancini3, Paola Carioni2, Graziella D'Arrigo1, Attilio Di Benedetto4, Fabrizio Cerino4, Carmela Marino1, Antonio Vilasi1, Giovanni Tripepi1, Stefano Stuard2, Giovanbattista Capasso5, Antonio Santoro6, Carmine Zoccali7.   

Abstract

In 2013, the Italian Society of Nephrology joined forces with Nephrocare-Italy to create a clinical research cohort of patients on file in the data-rich clinical management system (EUCLID) of this organization for the performance of observational studies in the hemodialysis (HD) population. To see whether patients in EUCLID are representative of the HD population in Italy, we set out to compare the whole EUCLID population with patients included in the regional HD registries in Emilia-Romagna (Northern Italy) and in Calabria (Southern Italy), the sole regions in Italy which have systematically collected an enlarged clinical data set allowing comparison with the data-rich EUCLID system. An analysis of prevalent and incident patients in 2010 and 2011 showed that EUCLID patients had a lower prevalence of coronary heart disease, peripheral vascular disease, heart failure, valvular heart disease, liver disease, peptic ulcer and other comorbidities and risk factors and a higher fractional urea clearance (Kt/V) than those in the Emilia Romagna and Calabria registries. Accordingly, survival analysis showed a lower mortality risk in the EUCLID 2010 and 2011 cohorts than in the combined two regional registries in the corresponding years: for 2010, hazard ratio (HR) EUCLID vs. Regional registries: 0.80 [95% confidence interval: 0.71-0.90]; for 2011, HR: 0.76 [0.65-0.90]. However, this difference was nullified by statistical adjustment for the difference in comorbidities and risk factors, indicating that the longer survival in the EUCLID database was attributable to the lower risk profile of patients included in that database. This preliminary analysis sets the stage for future observational studies and indicates that appropriate adjustment for difference in comorbidities and risk factors is needed to generalize to the Italian HD population analyses based on the data-rich EUCLID database.

Entities:  

Keywords:  For-profit; Hemodialysis; Mortality; Public; Risk

Mesh:

Year:  2017        PMID: 28205136     DOI: 10.1007/s40620-016-0372-8

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  13 in total

1.  When money is the mission--the high costs of investor-owned care.

Authors:  S Woolhandler; D U Himmelstein
Journal:  N Engl J Med       Date:  1999-08-05       Impact factor: 91.245

2.  Ownership of dialysis facilities and patients' survival.

Authors:  A R Nissenson; W F Owen
Journal:  N Engl J Med       Date:  2000-04-06       Impact factor: 91.245

Review 3.  The importance of large, high quality clinical databases in nephrology.

Authors:  C Zoccali
Journal:  J Nephrol       Date:  2001 Nov-Dec       Impact factor: 3.902

4.  Survival in patients treated by long-term dialysis compared with the general population.

Authors:  Maurizio Nordio; Aurelio Limido; Umberto Maggiore; Michele Nichelatti; Maurizio Postorino; Giuseppe Quintaliani
Journal:  Am J Kidney Dis       Date:  2012-02-22       Impact factor: 8.860

5.  Treatment of end-stage renal disease: free but not equal.

Authors:  A S Relman; D Rennie
Journal:  N Engl J Med       Date:  1980-10-23       Impact factor: 91.245

Review 6.  Observational research databases in renal disease.

Authors:  Michael Shlipak; Catherine Stehman-Breen
Journal:  J Am Soc Nephrol       Date:  2005-11-09       Impact factor: 10.121

Review 7.  EuCliD (European Clinical Database): a database comparing different realities.

Authors:  D Marcelli; J Kirchgessner; C Amato; H Steil; A Mitteregger; V Moscardò; C Carioni; G Orlandini; E Gatti
Journal:  J Nephrol       Date:  2001 Nov-Dec       Impact factor: 3.902

8.  Comparative effectiveness of calcium-containing phosphate binders in incident U.S. dialysis patients.

Authors:  Wolfgang C Winkelmayer; Jun Liu; Bryan Kestenbaum
Journal:  Clin J Am Soc Nephrol       Date:  2010-10-14       Impact factor: 8.237

9.  Patient-centered medicine. A professional evolution.

Authors:  C Laine; F Davidoff
Journal:  JAMA       Date:  1996-01-10       Impact factor: 56.272

10.  Development and validation of a predictive mortality risk score from a European hemodialysis cohort.

Authors:  Jürgen Floege; Iain A Gillespie; Florian Kronenberg; Stefan D Anker; Ioanna Gioni; Sharon Richards; Ronald L Pisoni; Bruce M Robinson; Daniele Marcelli; Marc Froissart; Kai-Uwe Eckardt
Journal:  Kidney Int       Date:  2015-02-04       Impact factor: 10.612

View more
  2 in total

1.  Chronic hemodialysis patients with COVID-19 cared for by the public health system have higher mortality than those treated in private facilities: analysis of the Brazilian dialysis registry.

Authors:  Helbert do Nascimento Lima; Fabiana Baggio Nerbass; Osvaldo Merege Vieira Neto; Ricardo Sesso; Jocemir Ronaldo Lugon
Journal:  Int Urol Nephrol       Date:  2022-08-22       Impact factor: 2.266

2.  Clinical outcomes of hemodialysis patients in a public-private partnership care framework in Italy: a retrospective cohort study.

Authors:  L A Pedrini; A C Winter; F Cerino; A M Zawada; M Garbelli; A Feuersenger; A Feliciani; P Ruggiero; S Civardi; C Amato; B Canaud; S Stuard; A Karch; A Gauly
Journal:  BMC Nephrol       Date:  2019-02-01       Impact factor: 2.388

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.